Literature DB >> 30462488

Synergistic Nanozymetic Activity of Hybrid Gold Bipyramid-Molybdenum Disulfide Core@Shell Nanostructures for Two-Photon Imaging and Anticancer Therapy.

Swarup Kumar Maji1,2, Subin Yu1, Kyungwha Chung1, Madeshwaran Sekkarapatti Ramasamy1, Ju Won Lim1, Jianfang Wang3, Hyukjin Lee4, Dong Ha Kim1,5.   

Abstract

In recent years, the concept of combined therapy using gold hybrid nanomaterials has been broadly adopted to pioneer new anticancer treatments. However, their synergistic anticancer effects have yet to be thoroughly investigated. Herein,a hybrid gold nanobipyramid nanostructure coated with molybdenum disulfide (MoS2) semiconductor (AuNBPs@MoS2) was proposed as a smart nanozyme for anticancer therapy and two-photon bioimaging. The hybrid material showed dramatically enhanced localized surface plasmon resonance property under excitation owing to its anisotropic nature, coupled with the rich electron density in MoS2, resulting in the superior in situ photogeneration of reactive oxidative species (ROS - 1O2, •OH). We demonstrated that the synergistic effect of enhanced photothermal conversion and generation of ROS could increase the anticancer effect of AuNBPs@MoS2. Two-photon luminescence imaging confirmed that AuNBPs@MoS2 was successfully internalized in cancer cells and that simultaneous anticancer treatments based on catalytic and photothermal therapy could be achieved. This study highlighted, for the first time, a novel approach of plasmon-mediated powerful anticancer therapy and imaging via the unprecedented combination of anisotropic AuNBPs and two-dimensional MoS2 material.

Entities:  

Keywords:  gold nanobipyramid; localized surface plasmon resonance; photodynamic therapy; photothermal therapy; two-photon imaging

Mesh:

Substances:

Year:  2018        PMID: 30462488     DOI: 10.1021/acsami.8b15443

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  8 in total

Review 1.  2D material-based peroxidase-mimicking nanozymes: catalytic mechanisms and bioapplications.

Authors:  Jia Yang; Henghan Dai; Yue Sun; Lumin Wang; Gang Qin; Jinyuan Zhou; Qiang Chen; Gengzhi Sun
Journal:  Anal Bioanal Chem       Date:  2022-03-02       Impact factor: 4.142

2.  Anisotropic Plasmonic Gold Nanorod-Indocyanine Green@Reduced Graphene Oxide-Doxorubicin Nanohybrids for Image-Guided Enhanced Tumor Theranostics.

Authors:  Swarup Kumar Maji; Subin Yu; Eunshil Choi; Ju Won Lim; Dohyub Jang; Ga-Young Kim; Sehoon Kim; Hyukjin Lee; Dong Ha Kim
Journal:  ACS Omega       Date:  2022-04-22

Review 3.  Graphene and other 2D materials: a multidisciplinary analysis to uncover the hidden potential as cancer theranostics.

Authors:  Laura Fusco; Arianna Gazzi; Guotao Peng; Yuyoung Shin; Sandra Vranic; Davide Bedognetti; Flavia Vitale; Acelya Yilmazer; Xinliang Feng; Bengt Fadeel; Cinzia Casiraghi; Lucia Gemma Delogu
Journal:  Theranostics       Date:  2020-04-07       Impact factor: 11.556

Review 4.  Recent Trends in Photoacoustic Imaging Techniques for 2D Nanomaterial-Based Phototherapy.

Authors:  Woo Yeup Jeong; Moon Sung Kang; Haeni Lee; Jong Hun Lee; Jeesu Kim; Dong-Wook Han; Ki Su Kim
Journal:  Biomedicines       Date:  2021-01-15

Review 5.  Transition Metal Dichalcogenides (TMDC)-Based Nanozymes for Biosensing and Therapeutic Applications.

Authors:  Dario Presutti; Tarun Agarwal; Atefeh Zarepour; Nehar Celikkin; Sara Hooshmand; Chinmay Nayak; Matineh Ghomi; Ali Zarrabi; Marco Costantini; Birendra Behera; Tapas Kumar Maiti
Journal:  Materials (Basel)       Date:  2022-01-04       Impact factor: 3.623

Review 6.  Gold Nanozymes: From Concept to Biomedical Applications.

Authors:  Javier Lou-Franco; Bhaskar Das; Christopher Elliott; Cuong Cao
Journal:  Nanomicro Lett       Date:  2020-10-27

Review 7.  Nanomaterial-Based Tumor Photothermal Immunotherapy.

Authors:  Peng Xu; Feng Liang
Journal:  Int J Nanomedicine       Date:  2020-11-19

Review 8.  Gold-Polymer Nanocomposites for Future Therapeutic and Tissue Engineering Applications.

Authors:  Panangattukara Prabhakaran Praveen Kumar; Dong-Kwon Lim
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.